Chemistry, Crystal Structure, and In Vitro Receptor Binding of Δ10-THC Isomers
- 1 September 2023
- journal article
- research article
- Published by SAGE Publications in Cannabis & Cannabinoid Research
- Vol. 8 (S1) , S1-S10
Abstract
Introduction: The psychoactive properties of Δ10-THC isomers (trans- and cis-Δ10-THC) are poorly understood. To shed more light on the biological effects of these compounds, we studied in vitro receptor binding of Δ10-THC isomers at cannabinoid CB1 and CB2 receptors. Materials and Methods: We first optimized and simplified catalytic synthesis of trans- and cis-Δ10-THC to allow their safe and cheap large-scale synthesis. In our synthesis, BuLi was replaced with KOtBu, and DMSO/anisole or NEt3/heptane solvent systems were used instead of HMPA/toluene. Single crystal X-ray analysis confirmed the structure of both isomers and the configuration of their chiral centers. Results: In the radioligand replacement assay, both isomers showed strong affinity toward the CB1 receptor, with IC50=29.1 nM for the trans isomer and IC50=294.2 nM for the cis counterpart. However, the IC50 values were significantly higher than that of Δ9-THC (2.1 nM), a naturally occurring psychoactive component of cannabis sativa, suggesting a lower affinity of Δ10-THCs toward this receptor. In function assays, in contrast to Δ9-THC, both isomers failed to show any agonist properties at concentrations up to 10 μM suggesting a lack of THC-like psychoactivity for trans- and cis-Δ10-THC. Conclusions: Our results established Δ10-THC isomers among antagonists of the CB1 receptor as both cis and trans isomers antagonized CP55,490 with IC50=460 nM for trans and IC50=1040 nM for cis. This functional property has not been previously observed for any other THC isomers.Keywords
This publication has 26 references indexed in Scilit:
- Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questionsInternational Journal of Obesity, 2009
- Mercury CSD 2.0– new features for the visualization and investigation of crystal structuresJournal of Applied Crystallography, 2008
- Functional Selectivity and Classical Concepts of Quantitative PharmacologyThe Journal of Pharmacology and Experimental Therapeutics, 2007
- The importance of the orientation of the C9 substituent to cannabinoid activityJournal of Medicinal Chemistry, 1989
- Base-catalysed double-bond isomerizations of cannabinoids: structural and stereochemical aspectsJournal of the Chemical Society, Perkin Transactions 1, 1984
- Potassium tert-butoxide in synthesisChemical Reviews, 1974
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- Hashish VI1: Conversion of (-)-Δ 1(6)-Tetrahydrocannabinol to (-)-Δ 1(7)-Tetrahydrocannabinol. Stability of (-)-Δ 1 and (-)-Δ 1(6)-TetrahydrocannabinolsCellular and Molecular Life Sciences, 1972
- Evaluation of base-solvent systems using olefin isomerization as a probeThe Journal of Organic Chemistry, 1972
- STRUCTURAL REQUIREMENTS FOR CANNABINOID ACTIVITY*Annals of the New York Academy of Sciences, 1971